New behavioral program aims to curb HIV and drug use in High-Risk men
NCT ID NCT07281378
First seen Jun 24, 2026 · Last updated Jul 01, 2026 · Updated 3 times
Summary
This study tests a six-session behavioral program for stimulant-using men at high risk for HIV. The program focuses on positive thinking, mindfulness, and building supportive networks to help participants start taking PrEP (a daily pill that prevents HIV) and reduce stimulant use and risky sex. The trial will enroll 84 men across the U.S. to see if the program is feasible and acceptable.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Tailored Positive Affect Intervention (behavioral counseling sessions)
- What this could lead to
- If it works, this could point toward an effective way to help stimulant-using men start PrEP and lower their HIV risk.
- What could go wrong
- This is a small pilot study (84 people) testing feasibility, not proof of effectiveness. Results may not apply broadly, and behavioral interventions can have mixed success.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG USE DISORDERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Long-acting HIV shot study aims to make prevention fairer for all
- STI tests boost HIV prevention in pregnant women
- Can a single chat with a partner keep people who inject drugs in care?
- Can smartphone apps help fight addiction in primary care? large study tests new approach.
- Can a phone app help end HIV stigma and boost prevention?
- App and home delivery aim to keep youth HIV-free